Purdue to pay $8.3bn after admitting criminal charges in opi...

After years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in the US opioid epidemic that will cost it up to $8.3 billion.

After final $600M opioid settlement, Indivior looks to the f...

UK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in the US behind it, after agreeing a $600 million settlement.

Orexo eyes launch of digital therapy for heavy drinkers this...

Addiction firm Orexo licenses app for alcohol use disorder

England is risking its own opioid epidemic, says PHE

FDA to reconsider Braeburn's opioid addiction drug after cou...

A US district court has ruled that the FDA must reconsider its decision to reject a long-lasting opioid addiction treatment drug from Braeburn, overthrowing a ruling granting exclusivity to